Latest Breaking News On - ேசை நிறுவனம் - Page 1 : comparemela.com

(1) Centessa Pharmaceuticals ( Centessa ), a pharmaceutical company consisting of 10 subsidiary companies advancing a portfolio of high conviction programs with strong biological validation, today announced key additions to its leadership team. Gregory Weinhoff, M.D., MBA, joined the team as chief financial officer, while Mary Lynne Hedley, Ph.D., Robert M. Califf, M.D., MACC, and Samarth Kulkarni, Ph.D., joined Centessa s board of directors effective February 23, 2021. Centessa launched last month with a goal of redefining pharmaceutical R&D productivity through an asset-centric model that we believe has the potential to support the advancement of novel programs by industry-leading experts in their respective fields, said Saurabh Saha, M.D., Ph.D., chief executive officer of Centessa. Each member of our team brings industry-leading qualifications and differentiated perspectives to help guide the expansion of our organization. We are thrilled to welcome Greg, Mary Lynne, Robert

United kingdomDan budwickSamarth kulkarniShabnam bashirSaurabh sahaGregory weinhoffKostenloser wertpapierhandelAngelini pharmaRobertm califfMary clarkMary lynne hedleyMary lynneAmicus therapeuticsPurdue universityBroad instituteDuke university school of medicine